Merlin et al. demonstrated, that ECP-treatment of patients who suffered from GVHD, lead to an increase of arginase-1 activity and expression in the blood of these patients and that by this mechanism important inflammatory cytokines could be regulated [50]. Here, ARG1 is linked to graft versus host disease.